Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

Chen Liu,He Cheng,Kaizhou Jin,Zhiyao Fan,Yitao Gong,Yunzhen Qian,Shengming Deng,Qiuyi Huang,Quanxing Ni,Xianjun Yu,Guopei Luo

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy

2020

Chen Liu
He Cheng
Kaizhou Jin
Zhiyao Fan
Yitao Gong
Yunzhen Qian
Shengming Deng
Qiuyi Huang
Quanxing Ni
Xianjun Yu
Guopei Luo

Lymphatic metastasis is a major determinant of the outcome of resected pancreatic cancer. Gemcitabine-based adjuvant chemotherapy can improve the outcome of resected pancreatic cancer. However, the...

Keywords:

Pancreatic cancer
Pathology
Medicine
Gemcitabine
Chemotherapy
Adjuvant
Oncology
Refractory
Internal medicine
Regimen
Hazard ratio
Adenocarcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations